CAS RN: 1427475-17-9
N-(3-Indolinylmethyl)benzylamine
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1427475-17-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1427475-17-9 / N-benzyl-1-(2,3-dihydro-1H-indol-3-yl)methanamine
Standard CAS: 1427475-17-9
Multi CAS: No
Basic Information
copy
CAS
1427475-17-9 copy
Multi CAS
No copy
Molecular Formula
C16H18N2 copy
Molecular Weight
238.330000 copy
Exact Mass
238.146999 copy
SMILES
C1C(C2=CC=CC=C2N1)CNCC3=CC=CC=C3 copy
InChI
InChI=1S/C16H18N2/c1-2-6-13(7-3-1)10-17-11-14-12-18-16-9-5-4-8-15(14)16/h1-9,14,17-18H,10-12H2 copy
InChIKey
INGHOQQVVBBPJH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.25 copy
Rotatable bonds
4 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
75.82 copy
TPSA
24.06 copy
LogP / Solubility
WLOGP
2.99 copy
MLOGP
2.63 copy
XLogP3
2.8 copy
Consensus LogP
2.81 copy
Log S (ESOL)
-3.43 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.67 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.17 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.05 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy